abstract |
(57) [Summary]nThe present invention provides a purified and isolated polynucleotide molecule encoding a Chlamydia polypeptide that can be used in a method for preventing, treating or diagnosing a Chlamydia infection. In one aspect of the invention, the polynucleotide molecule comprises the polynucleotides CPN100377 (SEQ ID NOs: 1 and 2), CPN100421 (SEQ ID NOs: 3 and 4), CPN100422 (SEQ ID NOs: 5 and 6), CPN100424 (SEQ ID NOs: 7 and 8), CPN100426 (SEQ ID NOS: 9 and 10), CPN100508 (SEQ ID NOs: 11 and 12), CPN100515 (SEQ ID NOs: 13 and 14), CPN100538 (SEQ ID NOs: 15 and 16), CPN100557 (SEQ ID NOs: 17 and 18), CPN100622 (SEQ ID NO: 19) And 20), CPN100626 (SEQ ID NOs: 21 and 22), CPN100628 (SEQ ID NOs: 23 and 24) and CPN100630 (SEQ ID NOs: 25 and 26) Be-option. |